MAPT and Alzheimer disease: These findings were further confirmed by immunoblotting analysis of hippocampal samples, which showed a significant increase in the gauche P-tau conformer in AD brains (1.38 ± 0.35 vs. 0.38 ± 0.13, n = 5, p = 0.031) (Figure 1c).